Docosahexaenoic acid (DSM)

二十二碳六烯酸

Report date: 2025/12/24 16:28:58

Base Information

Drug NameDocosahexaenoic acid (DSM)
Drug Alias NameDHA - Martek BiosciencesNeurominsDHASCOLife'sDHADHA GOLD +[6] 
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityNeurocognitive DisordersNutrition Disorders
Global Approved IndicationsNutrition Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/01/12
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesDsm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFudan UniversityUniversity Of Cincinnati
Active IndicationsNutrition Disorders
Inactive IndicationsAttention Deficit Disorder with HyperactivityNeurocognitive Disorders

Other Information

ATC CodeV06D
Related LinksWikipediaDrugBankKEGG